Larvol Delta - JS014-Combined-With-Toripalimab-and-TACE-in-Unresectable-HCC-a-Phase-Ib-Study

JS014 - Shanghai Junshi Biosci, Anwita Biosci

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT06882876

Sep 20, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next